FDA Inspection 938893 — Carter BloodCare - Addison

Carter BloodCare - Addison — FEI 3003755235

The FDA completed an inspection of Carter BloodCare - Addison on July 20, 2015 in Addison, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 20, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Addison, TX (United States)